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Nanoelectrospray (nanoES) tandem mass spectrometry was used to examine covalently 
modified peptides in crude enzymatic digests of human serum albumin (HSA) that had been 
exposed to either benzo[a]pyrene diol epoxide (B[a]PDE, 1), chrysene diol epoxide (CDE, 2), 
5-methylchrysene diol epoxide (5MeCDE, 3), or benzo[g]chrysene diol epoxide (B[g]CDE, 4). 
The low flow rates of nanoES (~20 nL/min) allowed several MS/MS experiments to be 
optimized and performed on a single sample with very little sample consumption (~30 rain 
analysis time//xL sample). Initially, nanoES was compared with conventional LC/MS/MS 
analysis of carcinogen-peptide adducts. For example, nanoES analysis of an unseparaled 
digest of B[a]PDE-treated serum albumin revealed the same peptides (RRHPY and RRHPY- 
FYAPE) that were previously shown, by LC/MS/MS, to be adducted with B[alPDE. In 
addition, nanoES could detect unstable peptide adducts that might not otherwise have been 
directly observable. Finally, nanoES was shown to be an effective way to screen mixtures of 
modified and unmodified peptides for which no chromatographic information is available. 
(J Am Soc Mass Spectrom 1998, 9, 202-207) © 1998 American Society for Mass Spectrometry 
D 
irect-acting carcinogens and electrophilic ar- 
icinogen metabolites form adducts both with 
DNA and with proteins, and the levels of such 
adducts in humans can potentially serve as indices of 
individual exposure to genotoxic agents [1-7]. The 
protein adducts--although not directly involved in 
genoto:dcity--have b en more widely studied in this 
context for several reasons, including the ease of obtain- 
ing reasonable amounts of protein, the absence of repair 
mechanisms, and the observation that the adduct levels 
increase to a relatively high steady state because of the 
lifetime, of the proteins and the stability of the adducts 
[5-7]. We and others have studied the interactions of 
carcinogen metabolites with serum proteins and have 
obserwtd that several polycyclic aromatic diol epoxides 
(PAHDE) react with human serum albumin (HSA), 
with a high degree of regioselectivity, to form stable 
covaler~t adducts with either Lys(137) or His(146) in the 
IB subdomain of HSA [8-10]. Mass spectrometry has 
been a major tool for the characterization of these 
adduction sites. Much of this work has been with fast 
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atom bombardment collision-induced dissociation 
(CID) MS/MS I10] and--more recently--with electro- 
spray CID MS/MS [8], following isolation or separa- 
tion, e.g., by HPLC, of the adducted peptides from 
enzymatic digests prior to MS/MS analysis. 
Nanoelectrospray (or nanoES), pioneered by Mann 
and coworkers at the European Molecular Biology 
Laboratory (EMBL), has been shown to be a sensitive 
and powerful tectmique for analysis of peptides in 
small sample volumes, i.e., on the order of 1-3 /xL 
[11-14]. The low flow rates obtained with nanospray 
allow multiple MS/MS experiments to be carried out 
during a single sample run (30-60 min analysis 
t ime/ /4  sample). In contrast o nanoES, conventional 
electrospray experiments, e.g., with HPI_C or flow in- 
jection, require larger sample w~lumes for tandem mass 
spectrometry experiments, and often require nmltiple 
sample injections. Due to the increased analysis times 
afforded by nanoES, it is possible to adjust the instru- 
ment conditions to obtain optimum C[D spectra in turn 
for each component in a mixlure, and this has been 
exploited, for example, to sequence peptides in unsepa- 
rated protein digests via tandem mass spectrometry [113, 
15-17]. In this report, we describe the analysis and 
sequencing of peptide adducts (see Figure 1 for PAHDE 
structures) from crude proteolytic digests by nanoES 
tandem mass spectrometry. 
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Figure 1. Structures of polycyclic aromatic hydrocarbon epoxides 
and diol epoxides. The numbers in parentheses represent the ion 
clusters for the PAH diol epoxides, and correspond to the respective 
[M+H] ÷, [M+H] ~ - H20, and [M+H] ~ - H:!O - CO ions. 
Experimental 
Materials 
Fatty-acid-free human serum albumin was purchased 
from Sigma (St. Louis, MO). (+_)-r-7,t-8-Dihydroxy-t- 
9,t-10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene nd (±)-r- 
1,t-2-dihydroxy-t-3,4-oxy-l,2,3,4-tetrahydrochrysene were 
purchased from the NCI Chemical Carcinogen Repository 
maintained by Chemsyn Science Laboratories (Lenexa, 
KS). ( ± )-r-l,t-2-Dihydroxy-t-3,4-oxy-l,2,3,4-tetrahydro-5- 
methylchrysene and (+_)-r-ll,t-12-dihydroxy-t-13,14-oxy- 
11,12,13,14-tetrahydro-benzo[g]chrysene wer  kindly pro- 
vided by Dr. Shantu Amin (American Health Foundation, 
Valhalla, NY). Proteinase K was obtained from Boehringer 
Mannheim (Mannheim, Germany). Gold-coated nanoelec- 
trospray capillaries were purchased from The Protein 
Analysis Company (Odense, Denmark). 
Mass Spectrometry 
Mass spectrometry [8] on positive ions was done on a 
Finnigan TSQ 7000 tandem quadrupole mass spectrom- 
eter (Finnigan Corp., San Jose, CA.), using either the 
standard Finnigan electrospray ion source or a custom- 
designed "nanospray" ion source. Tuning for both ion 
sources was done on a peptide mixture of valine, 
trityrosine, and hexatyrosine in 80:20 water:isopropanol 
with 2'}/0 propionic acid. The instrument conditions 
varied with the sample and the method of sample 
introduction. For on-line LC-MS or flow injections at 
flows in the 100-400 /zL/min range, both sheath gas 
(40-80 psi) and auxiliary gas (10%-60% flow-meter 
scale) were used. For flows in the 2-5 /~L/min range, 
only sheath gas was generally used. Neither sheath gas 
nor auxiliary gas was necessary with flow rates lower 
than 2 /zL/min. For single quadrupole mass analysis, 
mass spectra were acquired by scanning the Q1 ana- 
lyzer at a rate of 2 s/scan over a range of 100-1100 m/z ,  
with Q2 and Q3 operating in the if-only mode. For 
collision-induced issociation (CID) experiments, i.e., 
precursor and product ion scan modes, argon was the 
collision gas at pressures of 2--4 mtorr. Collision offset 
voltages were typically between -15 and -30 V. In 
nanospray experiments with protein digests, the condi- 
tions were adjusted in real time on individual molecular 
ions to obtain optimal product-ion spectra for each 
compound of interest. 
Nanospray lolt Source 
The basis of nanoelectrospray ion sources is a low 
solvent flow maintained by a voltage applied to a 
metal-coated glass capillary that has been drawn to a tip 
with an i.d. of about 1 /~m [11, 12]. The capillary is 
mounted on a microscope stage that allows placement 
of the spray tip to within 1-2 mm of the inlet orifice of 
the mass spectrometer (as viewed with a stereomicro- 
scope). In our design, the capillary is held in place by a 
standard Swagelok TM fitting and a conductive graphite 
ferrule. Voltage is applied from the mass spectrometer 
high voltage power supply and is typically in the range 
1.0-3.0 kV (as indicated by the voltage readout on the 
mass spectrometer data system; the actual voltage at the 
spray tip is not measured). Experiments are started with 
the instrument scanning and the voltage at about I kV. 
The voltage is gradually increased until a stable signal 
is observed and it is then adjusted for maximum 
signal-to-noise ratio. Due to inconsistencies in the exact 
placement of the spray tip, the density of metal coating, 
and the tightness of the ferrule, the onset voltage and 
the flow rate are not precisely reproducible. The spray, 
however, generally begins at about 1.6 kV and the flow 
rate is typically in the range of 20-40 nL/min, corre- 
sponding roughly to about 0.5--1 h/t-~L of solution. 
Preparation of PAHDE-Peptide Adducts 
A solution of the diol epoxide (0.25 mg in 50/~L THF) 
was added to a solution of human serum albumin (25 
mg) dissolved in 10 mM sodium/potassium phosphate- 
buffered normal saline, pH 7.4 (1 mL). After stirring for 
2 h at 37°C, the reaction was stopped by extraction with 
ethyl acetate and H20-saturated n-butanol (3 × 2 mL). 
The protein was linearized by reduction of the disulfide 
linkages with triethylphosphine (1 mL, 1% solution in 
n-propanol) and the resulting sulfllydryl groups were 
deactivated by alkylation with 4-vinyl-pyridine (25/zL) 
for 2 h at 37°C (see [18] and [19] for brief discussions of 
this concept and [20] for a recent example). Excess 
reagent was removed by extraction with ethyl acetate 
(3 × 2 mL). Adducted protein was then dialyzed 
overnight against 4 M urea (50(I mL containing 50 mM 
tris buffer, pH 8.3). Proteinase K (2% w/w)  was added 
and the dialysate was incubated for 6 h at 37°C. An 
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at m/z  303, m/z  285, and m/z 257 for B[a]PDE [8, 10, 
21]. This behavior was common to all of the diol 
epoxide-peptide adducts investigated in this study. 
Therefore, when Q3 is set to transmit one of these ions, 
and Q1 is scanned, the resulting mass spectra contain 
only ions that fragment to yield the selected ion under 
CID conditions and thus have a high probability of 
containing the PAHDE moiety. Once precursor ions 
corresponding topotential diol epoxide-containing sub- 
stances are observed, product ion spectra are obtained 
by setting Q1 to transmit he ion of interest, and then 
scanning Q3 under CID conditions. 
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Figure 2. Identification of B[a]PDE-peptide adducts via nano- 
electrospray-MS/MS. (a) Positive ion nanoelectrospray precursor 
ion spectrum (on m/z 257) of an unseparated proteinase K digest 
of B[a]PDE-treated HSA. Two major ions ([M+2H] 2+, m/z 516.0) 
and ([M+2H] 2+, m/z 819.8) correspond to B[a]PDE-RRHPY and 
B[a]PDE-RRHPYFYAPE, respectively. (b) Product-ion spectrum of 
m/z 516.0: singly protonated ions 303.2, 285.4 and 256.9 corre- 
spond |o the B[a]PDE moiety, ions 364.2 and 728.6 correspond to 
the doubly and singly charged peptide, RRHPY, respectively. (c) 
Product-ion spectrum of rn/z 819.8: singly protonated ions 303.3, 
285.2, and 257.0 correspond to the B[a]PDE moiety, ions 668.2 and 
1336.4 correspond to the doubly and singly charged peptide, 
RRHPYFYAPE, respectively. 
aliquot of the resulting digestion mixture was diluted 
with an equal volume of methanol and transferred to a 
nanospray glass capillary with a 10-/~L syringe. (The i.d. 
of the capillaries is large enough to accommodate he 
needles from 5 or 10 p~L syringes, so salt- and particle- 
free solvents can be injected directly through the open 
ends of the capillaries into the drawn tips.) The spray 
was initiated as described above. For CID experiments, 
argon was the collision gas at a pressures of the order of 
2 × 10 -3 torr and typical collision energies of about -20  
eV. 
Results and Discussion 
Characterization of modified peptides in crude digests 
requires first of all that they be identified from among 
the other components of the mixture. In this case we 
exploited observations by several groups that CID 
spectra of PAH diol epoxide adducts consistently con- 
tain sets of ions corresponding to the singly protonated 
hydrocarbon moiety and fragments that arise from it by 
sequential loss of H20 and CO [8, 10, 21-23], e.g., peaks 
Identification ofPAHDE-Peptide Adducts by 
Nanospray-ESI MS~MS 
Benzo[a]pyrene dioI epoxide (1) adducts. An unseparated 
proteinase K digest of albumin exposed to I was 
analyzed by positive-ion anoES in both the single MS 
(Q1) and MS/MS modes, with switching between these 
modes during a single sample run. Analysis of the digest 
in the Q1 mode revealed the presence of [M+2H] 2÷ ions at 
m/z 516.2 and m/z 820.1, albeit at low relative abundance. 
These two ions had been previously shown by LC-ESI 
MS/MS [8] to correspond to doubly charged B[a]PDE- 
R144RHPY 14s and B[a]PDE-Rla4RHPYFYAPE ls3 peptide 
adducts, respectively. Switching to precursor-ion scan- 
ning on m/z 257 resulted in the production of 
[M+2H] 2~ ions at m/z  516.0 and m/z 819.8 as the 
dominant ions (Figure 2a). Product-ion scans on m/z 
516.0, again as part of the same experiment, produced 
ions corresponding to the expected m/z of the proto- 
nated hydrocarbon moiety and its fragments, as well as 
ions at m/z 364.2 and m/z 728.6, that correspond to 
the doubly and singly charged peptide, 1CRHPY (Figure 
2b). Product-ion scans on m/z 819.6 gave rise to ions 
from the hydrocarbon portion of the peptide adduct, 
and to ions at m/z 668.2, and m/z 1336.4 correspond- 
ing to the doubly and singly charged peptide RRHPY- 
FYAPE (Figure 2c:). Taken together, the precursor and 
product ion scans confirm the presence of the putative 
B[a]PDE-R1LHPY and B[a]PDE-RRHPYFYAPE adducts 
in the crude digest (the site of adduction was shown 
previously to be ~is  146 [8--10]). 
Chrysene diol epoxide (2) adducts. The unseparated pro- 
teinase K digest of albumin that had been treated with 
the 1,2-diol 3,4-epoxide of chrysene was examined by 
nanoES and compared to earlier findings with MS/MS 
analyses of isolated HPLC peaks. Positive-ion nanoES 
precursor-ion analysis, at m/z 233 (protonated hydro- 
carbon-H20-CO ) gave [M+2H] 2. ions at m/z 503.9 
and m/z 807.7 in good abundance. An ion at m/z 
650.7 (that had not been observed by conventional 
LC/MS/MS experiments) was also detected (Figure 
3a). Low energy CID on ions m/z  503.9 and m/z 807.7 
gave in each case [M+H] ~ ions at m/z 279, m/z 261 
and 233 corresponding to the expected protonated 
J Am Soc Mass Spectrom 1998, 9, 202~207 NANOSPRAY MS OF CARCINOGEN-PEPTIDE ADDUCTS 205 
3a 503.9 ,0°1! II 050.7 8o7.7 
J t 
400 6O9 8OO 
m/z 
I 
1000 
3b 233.2 
100 ] 261,4 503.6 
I/279.4 I 
/ i/~04.31 
200 600 
rrdz 
3d 
"i1 
3c 
728.3 1001 
L I / 233.3  261.2 66i'3 
279.2 
' ' 0 ' , '  , . . . .  
10()0 200 600 
m/z 
233.2  
650.3 
261.3 i 
5 2.5 
279.1 
• . . . . . . . . .  ,. , , 
200 600 t000 
m/z 
807.4 
1000 
Figure 3. Identification of CDE-peptide adducts via nanoelectro- 
spray-MS/MS. (a) Positive-ion nanoelectrospray precursor-ion 
spectrum (on m/z 233) of an unseparated proteinase K digest of 
CDE-treated HSA. Two of the major ions ([M+2H] 2÷, m/z 503.9) 
and ([M+2H] 2+, m/z 807.7) were identified by product ion scans 
[(b) and (c)] as CDE-RRHPY and CDE-RRHPYFYAPE adducts, 
respectively. The precursor ion m/z 650.7 was also shown to 
contain the hydrocarbon asevidenced by the fragment ions at m/z 
279.1,261.3, and 233.2 (d). 
hydrocarbon and fragment ions from loss of water and 
carbon monoxide. In addition, product ions at m/z 
364.3 (from m/z 504) and m/z 668.3 (from m/z 808), 
corresponding to the doubly charged peptides, 
R144RHPY 148 and R144RHPYFYAPE 153, respectively, 
were observed (Figure 3b,c). Product ion analysis on 
m/z 650.7 also revealed the presence of the hydrocar- 
bon fragments as well as an [M+2H] 2+ ion at m/z 
512.5 (Figure 3d). The identity of this ion has not been 
determined, but there is evidence that diol epoxides of 
PAHs can form unstable adducts such as ester adducts 
with either aspartate or glutamate [24, 25]. Because 
nanoES requires no prior chromatography of the digest, 
in which ion-pairing agents, e.g., trifluoroacetic acid 
(TFA) are commonly used, labile adducts uch as those 
formed between aspartate or glutamate may be more 
readily observed. 
5-Methylchrysene and benzo[g]chrysene diol epoxide adducts 
(3 & 4). NanoES analysis of digests of albumin that 
had been treated with the diol epoxides of either 
5-methylchrysene or benzo/g]chrysene w re also inves- 
tigated. However, unlike benzo[a]pyrene diol ep- 
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Figure 4. Identification of 5MeCDE-peptide adducts via nano- 
electrospray-MS/MS. (a) Positive ion nanoelectrospray precursor- 
ion spectrum (on m/z 247) of an unseparated proteinase K digest 
of 5MeCDE-treated HSA. The major ion at m/z 715.5 was 
identified as a peptide adduct by nanoelectrospray product-ion 
spectrum (b). Ions at m/z 293.4, 275.2, and 247.3 correspond to 
the hydrocarbon fragments. The ion at m/z 423.5 was later 
determined to be the peptide portion of the adduct, see Figure 6. 
oxide--and chrysene diol epoxide--peptide adducts, 
peptide adducts formed between either 3 or 4 were 
initially investigated via nanoES. LC-MS/MS analyses 
of these digests were done later to determine if initial 
screening of the complete digest by nanoES could be 
useful in detecting and identifying unknown carcino- 
gen-peptide adducts. NanoES precursor-ion scans were 
performed at either m/z 247 or 283, i.e., the [M+H]* 
ions expected to arise from sequential loss of H20 and 
CO for 3 or 4, respectively. In the case of 3, a prominent 
[M+H] + ion at m/z 715.5 was observed (Figure 4a) 
and, precursor ion scans of the crude digest of HSA 
treated with 4 revealed a dominant ion at m/z 751.5 
(Figure 5a). During the respective sample runs the 
instrument was programmed to carry out product- ion 
scans on either m/z 715.5 or m/z 751.5. In each case, 
the product- ion spectrum contained fragments charac- 
teristic of the respective hydrocarbon (i.e., 3 or 4) as well 
as a common [M+H] + ion at m/z 423 (Figures 4b and 
5b). Based on the observation that PAHDE-peptide 
adducts undergo hydrocarbon-peptide fragmentation 
in the ion source to produce a charged peptide [8], the 
tube lens and capillary voltages in the source were 
optimized on m/z 423.3 in order to facilitate peptide 
sequencing following in-source CID. As in all previous 
cases, these experiments were done during the same 
sample run. The representative product ion CID spec- 
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Figure 5. Identification of B[g]CDE-peptide adducts via nano- 
electrospray-MS/MS. (a) Positive-ion anoelectrospray precursor- 
ion spectrum (on m/z 283) of an unseparated proteinase K digest 
of B[gJCDE-treated HSA. The product-ion spectrum arising from 
m/z 751.5 is shown in (b). The ions at m/z 328.7, 311.3, and 
283.2 are the characteristic hydrocarbon fragments. The ion at m/z 
423.2 corresponds tothe peptide, see Figure 6. 
trum for the peptide originating from the adduct of 
either 3 or 4 (Figure 6; for nomenclature, see [26]) is 
consistent with- -a l though not definitive for - -Lys -Tyr -  
Leu. This sequence is found in subdomain IB of albu- 
min (LyslB7-TyrJ38-Leu139), which is a common binding 
site foi PAH epoxides and diol epoxides [8]. In separate 
LC-MS experiments [8], 3 and 4 were shown to bind to 
lysines and 4 to a peptide that produced a CID spec- 
trum consistent with the sequence Lys~37-Tyr ~38- 
Leu 139__Tyr 14°" 
Conclusion 
In this study we have demonstrated the utility of 
nanoES, in three specific ways, as an effective means to 
investigate proteins that have been covalently modified 
by low molecular weight organic electrophiles, i.e., 
PAHDEs. This was achieved via enzymatic digestion of 
the modified protein, in our case serum albumin, fol- 
lowed by nanoES tandem mass spectrometric analyses 
of the unseparated igest and characterization of the 
carcinogen-peptide adducts. We gained initial confi- 
dence :in this technique by demonstrating that we could 
in fact observe carcinogen-peptide adducts in unsepa- 
rated digests via nanoES. This was accomplished by 
re-examination of B[a]PDE-peptide adducts in digests 
of B[a]PDE-treated albumin. In this experiment-- in 
which Qi precursor ion and product ion scans were 
y~ 
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Figure 6. CID spectrum of the peptide ion with m/z 423 via 
nanoetectrospray-MS/MS. Product-ion spectrum of presumed 
Lys137-Tyr138-Leu139 from the adduct of either 3 or 4. Following 
in-source CID, the ion at m/z 423.3, which corresponds to the 
peptide, was selected in Q1 and subjected to CID to yield the 
product-ion spectrum shown. 
performed on the digest during the same sample 
run- -we  were able to observe both the pentapeptide- 
and decapeptide-B[a]PDE adducts that had been de- 
tected earlier by conventional LC/MS/MS.  During 
nanoES analysis of the proteinase K digest of serum 
albumin reacted with 2, we not only detected peptide 
adducts that had been earlier observed by LC/MS/MS 
[8], but we also found an additional adduct that was 
either missed by LC/MS/MS or was not stable to the 
chromatographic conditions required to separate the 
individual adducts. Because no prior chromatography 
is required for nanoES analysis, this technique is an 
effective way to examine labile adducts. Last, nanoES 
was used as the initial technique to screen for the types 
of adducts that arise from serum albumin treated with 
either 3 or 4. Unlike the earlier two experiments, LC/  
MS/MS data were not available prior to these investi- 
gations. NanoES analyses of these two digests nonethe- 
less indicated that the tripeptide Lys137-TyrlgS-Leu 139, 
located in the IB subdomain of albumin, was adducted 
by 5-methylchrysene and benzo[~,qchrysene diol ep- 
oxides. This tripeptide adduct was subsequently ob- 
served as the major component when these digests were 
investigated by LC/MS/MS.  No attempt was made in 
this series of experiments to quantitate the adducts or to 
establish detection limits, although B[a]PDE-HSA and 
CDE-HSA adducts have been observed in other LC/  
MS/MS experiments at low femtomole lewds (unpub- 
lished). In summary, nanoES has proved to be a pow- 
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erful  techn ique for the detect ion and character izat ion of
covalent ly  mod i f ied  pept ides  in unchromatographed 
digests. 
Acknowledgments 
The authors thank the National Institutes of Health for continuing 
support (grant nos. ES04675, ES05622, and ES02109), and DOE for 
the mass spectrometer (grant no. DE-FG02-957E00056). 
References 
1. Calleman, C. J.; Ehrenberg, L.; Jansson, B.; Osterman-Golkar, 
S.; Segerback, D.; Sverisson, K.; Wachtneister, C. A. Monitor- 
ing and risk assessment by means of alkyl groups in hemo- 
globin in persons occupationally exposed to ethylene oxide. J. 
Environ. Pathol. Toxicol. 1978, 2, 427-444. 
2. Ehrenberg, L.; Osterman-Golkar, S. Alkylation of macrnmole- 
cules for detecting mutagenic agents. Teratog. Carcinog. Mutag, 
1980, 1,105-127. 
3. Osterman-Golkar, S.;Ehrenberg, L.; Segerback, D.; Hatlstrom, 
i. Evaluation of genetic risks of alkylating agents. II. Haemo- 
globin as a dose monitor. Mutat. Res. 1976, 34, 1-10. 
4. Osterman-Golkar, S.; Hultmark, D.; Segerback, D.; Calleman, 
C. J.; Gothe, R.; Ehrenberg, L.; Hallstrom, I. Alkylation of DNA 
and proteins in mice exposed to vinyl chloride. Biochem. 
Biophys. Res. Commun. 1977, 76, 259-266. 
5. Skipper, P. L.; Tamlenbaum, S. R. Protein adducts in the 
molecular dosimetry of chemical carcinogens. Carcinoxenesis 
1990, 11,507-518. 
6. Skipper, P. L.; Tannenbaum, S. R. Molecular dosimetry of 
aromatic amines in human populations. Environ. Health Persp. 
1994, 102, Suppl. 17-21. 
7. Tannenbaum, S. R.; Skipper, P. L.; Wishnok, ~. S.; Stitlwe]l, 
W. G.; Day, B. W.; Taghizadeh, K. Characterization f various 
classes of protein adducts. Environ. Health Persp. 1993, 99, 
51-55. 
8. Brunmark, P.; Harriman, S.; Skipper, P. L.; Wishnok, J. S.; 
Anlin, S.; Tannenbaum, S.R. Identification of subdomain IB in 
human serum albumin as a major binding site for polycyclic 
aromatic hydrocarbon epoxides. Chem. Res. Toxicol. 1997, 10, 
880-886. 
9. Day, B. W.; Skipper, P. L.; Zaia, J.; Tannenbaum, S. R. 
Benzo[a]pyrene anti-diol epoxide covalently modifies human 
serum albumin carboxylate side chains and imidazole side 
chain of histidine(146). ]. Am, Chem. Soc. 1991, 113, 8505-8509. 
10. Zaia, J.; Biemann, K. Characteristics of high energy collision- 
induced dissociation tandem mass spectra of polycyclic aro- 
matic hydrocarbon diolepoxide adducted peptides. ] Ant. Soc. 
Mass Spectrom. 1994, 5, 649-654. 
11. Wilm, M. S.; Mann, M. Electrospray and Taylor~Cone theory, 
Dole's beam of macromolecules at last? Int. J. Mass Spectrom. 
hm Proc. 1994, 136, 167-180. 
12. Wilm, M.; Mann, M. Analytical properties of the nanoelectro- 
spray ion source. Anal. Chem. 1996, 68, 1-8. 
13. Wilm, M.; Shevchenko, A.; Houthaeve, T.; Brelt, S.; Schweig- 
erer, L.; Fotsis, T.; Mann, M. Femtomole sequencing of pro- 
teins from polyacrylamide gels by nanoelectrospray mass 
spectrometry. Nature 1996, 379, 466-469. 
14. Shevchenko, A.; Wilm, M.; Vorm, O.; Mann, M. Mass spectro- 
metric sequencing of proteins from silver-stained polyacryl- 
amide gels. Anal. Chem. 1996, 68, 259-266. 
15. Davis, M. T.; Stahl, D. C.; Hefta, S. A.; Lee, T. D. A microscale 
electrospray interface for on-line, capillary liquid chromatng- 
raphy/tandem ass spectrometry of complex peptide mix- 
tures. Anal. Chem. 1995, 67, 4549 4556. 
16. Korner, R.; Wilm, M.; Morand, K.; Schubert, M. Nano electro- 
spray combined with a quadrupole ion trap for the analysis of 
peptides and protein digests. ]. Am. Soc, Mass Spectrom. 1996, 
7, 150-156. 
17. Valaskovic, G. A.; Kelleher, N. L.; Little, D. P.; Aasuerud, D. J.; 
McLafferty, F. W. Attomole sensitivity electrospray source for 
large-molecule mass spectrometry. Anal. Chem 1995, 67, 3802- 
3805. 
18. Stryer, L. Biochemistry; W. H. Freeman: New York, 1988, pp 
57-58. 
19. Allen, G., in Laboratory Techniques in Biochemistry and Molecular 
Bioloy, y; Burdon, R. H., van Knippenberg, P. H,  Eds.; Elsevier: 
New York, 1989, p 58. 
20. Baker, P.; Clauser, K. MS-FIT. bttp://prospector.ucsf.edu/ 
htmluscf/msfit-htm 
21. RamaKrishna, N. V. S.; Gao, F.; Padmavathi, N. S.; Cavalieri, 
E. L.; Rogan, E. G.; Cerny, R. L.; Gross, M. L. Model adducts of 
benzo[a]pyrene and nucleosides formed from its radical cation 
and diol epoxide. Chem, Res. Toxicol. 1992, 5, 293-301. 
22. Szeliga, J.; Page, J. E.; Hilton, B. D.; Kisetyov, A. S.; Harvey, 
R. G.; Dunayevskiy, Y. M.; Vouros, P.; Dipple, A. Character- 
ization of DNA adducts formed by anti-benzo[s]chrysene 
ll,12-dihydrodiol 13,14-epoxide. Chem. Res. Toxicol. 1995, 8, 
1014-1019. 
23. Annan, R. S.; Giese, R. W.; Vouros, P. Detection and structural 
characterization of amino polyaromatic hydrocarbon-de- 
oxynucleoside adducts using fast atom bombardment and 
tandem mass spectrometry. Anal. Biochem. 1990, 191, 86-95. 
24. Day, B. W.; Skipper, P. L.; Zaia, }.; Singh, K.: Tannenbaum, 
S. R. Enantiospecificity of covalent adduct formation by ben- 
zo[a]pyrene anti-diol epoxide with human serum albumin. 
Chem. Res. Toxicol. 1994, 7, 829-83-3. 
25. Day, B. W.; Skipper, P. L.; Rich, R. H.; Naylor, S.; Tannen- 
baum, S. R. Conversion of a hemoglobin alpha-chain aspar- 
tate(47) ester to N-(2,3-dihydroxypropyl)asparagine as a
method for the identification of the principal binding site for 
benzo[a]pyrene anti-diol epoxide. Chem. Res. Toxicol. 1991, 4, 
359 -363. 
26. Roepstorff, P.; Fohlman, J. Proposal for a common nomencla- 
ture fnr sequence ions in mass spectra of peptides. Biomed. 
Mass Spectrom. 1984, 11,601. 
